Skip to main content

Advertisement

SpringerLink
Log in

Interleukin13 haplotypes and susceptibility of Iranian women to breast cancer

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Interleukin-13 (IL-13) is a TH2 cytokine with direct and indirect immunoregulatory functions on cancer cells. The cytokine has been reported to have some polymorphic variations at the gene level associated with some immune related diseases including asthma and allergy. In the present study, association of three IL13 gene polymorphisms at positions −1512 A/C and −1055 C/T in the promoter and +2044 G/A in exon-4 was investigated in Iranian women with breast cancer and healthy controls. Genotyping of IL13 gene polymorphisms were performed by PCR–RFLP methods. Serum level of IL-13 was assessed by ELISA. Haplotypes were constructed from genotypic data using Arlequin 3.1 software package. Haplotype analysis revealed higher frequency of a three-locus haplotype, ACA (−1512A/−1055C/+2044A), in normal women than breast cancer patients (P < 0.025). Haplotype CCA, from the other hand, was observed with more frequency among patients than controls (P < 0.03). No statistically significant differences were found in the frequency of genotypes and alleles between patients and control group. No association was observed between investigated genotypes and other prognostic factors including tumor type, lymph node involvement and tumor size. IL-13 serum level was undetectable in both patients and control subjects. Despite observing no association between breast cancer and the single SNPs, results of this investigation suggest that the presence of CCA haplotype of IL13 gene may be associated with susceptibility of Iranian women to breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108

    Article  PubMed  Google Scholar 

  2. Ben-Baruch A (2003) Inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions. Breast Cancer Res 5:31–36. doi:10.1186/bcr554

    Article  PubMed  CAS  Google Scholar 

  3. Yu JL, Rak JW (2003) Inflammatory and immune cells in tumor angiogenesis and arteriogenesis. Breast Cancer Res 5:83–88. doi:10.1186/bcr573

    Article  PubMed  CAS  Google Scholar 

  4. Hadden JW (1999) The immunology and immunotherapy of beast cancer: an update. Int J Immunopharmacol 21:79–101. doi:10.1016/S0192-0561(98)00077-0

    Article  PubMed  CAS  Google Scholar 

  5. Wynn TA (2003) IL-13 effector functions. Annu Rev Immunol 21:425–456. doi:10.1146/annurev.immunol.21.120601.141142

    Article  PubMed  CAS  Google Scholar 

  6. Hershey GK (2003) IL-13 receptors and signaling pathways: an evolving web. J Allergy Clin Immunol 111:677–690. doi:10.1067/mai.2003.1333

    Article  PubMed  CAS  Google Scholar 

  7. Terabe M, Park JM, Berzofsky JA (2004) Role of IL-13 in regulation of anti-tumor immunity and tumor growth. Cancer Immunol Immunother 53:79–85. doi:10.1007/s00262-003-0445-0

    Article  PubMed  CAS  Google Scholar 

  8. Ellyard JI, Simson L, Parish CR (2007) Th2-mediated anti-tumour immunity: friend or foe? Tissue Antigens 70:1–11. doi:10.1111/j.1399-0039.2007.00869.x

    Article  PubMed  CAS  Google Scholar 

  9. Terabe M, Matsui S, Noben-Trauth N et al (2000) NKT cell mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol 1:515–520. doi:10.1038/82771

    Article  PubMed  CAS  Google Scholar 

  10. Ostrand-Rosenberg S, Sinha P, Clements V et al (2004) Signal transducer and activator of transcription 6 (Stat6) and CD1: inhibitors of immunosurveillance against primary tumors and metastatic disease. Cancer Immunol Immunother 53:86–91. doi:10.1007/s00262-003-0446-z

    Article  PubMed  CAS  Google Scholar 

  11. Shina P, Clements VK, Miller S et al (2005) Tumor immunity: a balancing act between T cell activation, macrophage activation and tumor-induced immune suppression. Cancer Immunol Immunother 54:1137–1142. doi:10.1007/s00262-005-0703-4

    Article  CAS  Google Scholar 

  12. Chaouchi N, Wallon C, Goujard C, et al. (1996) Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis. Blood 1022–1029

  13. Zaninoni A, Imperiali FG, pasquini C et al (2003) Cytokine modulation of nuclear factor-kappaB activity in B-chronic lymphocytic leukemia. Exp Hematol 31:185–189. doi:10.1016/S0301-472X(02)01046-9

    Article  PubMed  CAS  Google Scholar 

  14. Skinnider BF, Kapp U, Mak TW (2002) The role of interleukin 13 in classical Hodgkin lymphoma. Leuk Lymphoma 43:1203–1210. doi:10.1080/10428190290026259

    Article  PubMed  CAS  Google Scholar 

  15. Kapp U, Yeh WC, Patterson B et al (1999) Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells. J Exp Med 189:1939–1946. doi:10.1084/jem.189.12.1939

    Article  PubMed  CAS  Google Scholar 

  16. Aspord C, Pedroza-Gonzalez A, Gallegos M et al (2007) Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development. J Exp Med 204:1037–1047. doi:10.1084/jem.20061120

    Article  PubMed  CAS  Google Scholar 

  17. Serve H, Oelmann E, Herweg A et al (1996) Inhibition of proliferation and clonal growth of human breast cancer cells by IL-13. Cancer Res 56:3583–3588

    PubMed  CAS  Google Scholar 

  18. Blais Y, Gingras S, Haagensen DE et al (1996) Interleukin-4 and interleukin-13 inhibit estrogen-induced breast cancer cell proliferation and stimulate GCDFP-15 expression in human breast cancer cells. Mol Cell Endocrinol 121:11–18. doi:10.1016/0303-7207(96)03843-9

    Article  PubMed  CAS  Google Scholar 

  19. Obiri NI, Husain SR, Debinski W et al (1996) Interleukin 13 inhibits growth of human renal cell carcinoma cells independently of the p140 interleukin 4 receptor chain. Clin Cancer Res 2:1743–1749

    PubMed  CAS  Google Scholar 

  20. Renard N, Duvert V, Banchereau J et al (1994) Interleukin-13 inhibits the proliferation of normal and leukemic human B-cell precursors. Blood 84:2253–2260

    PubMed  CAS  Google Scholar 

  21. Tarazona-Santos E, Tishkoff SA (2005) Divergent patterns of linkage disequilibrium and haplotype structure across global populations at the interleukin-13 (IL-13) locus. Genes Immun 6:53–65

    PubMed  CAS  Google Scholar 

  22. Izuhara K, Arima K (2004) Signal transduction of IL-13 and its role in the pathogenesis of bronchial asthma. Drug News Perspect 17:91–98. doi:10.1358/dnp.2004.17.2.829041

    Article  PubMed  CAS  Google Scholar 

  23. Wills-Karp M (2000) The gene encoding interleukin-13: a susceptibility locus for asthma and related traits. Respir Res 1:19–23. doi:10.1186/rr7

    Article  PubMed  CAS  Google Scholar 

  24. Van der Pouw Kraan TC, van Veen A, Boeije LC et al (1999) An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes Immun 1:61–65. doi:10.1038/sj.gene.6363630

    Article  PubMed  CAS  Google Scholar 

  25. Heinzmann A, Mao XQ, Akaiwa M et al (2000) Genetic variants of IL-13 signalling and human asthma and atopy. Hum Mol Genet 9:549–559. doi:10.1093/hmg/9.4.549

    Article  PubMed  CAS  Google Scholar 

  26. Ohashi J, Naka I, Patarapotikul J et al (2003) A single-nucleotide substitution from C to T at position −1055 in the IL-13 promoter is associated with protection from severe malaria in Thailand. Genes Immun 4:528–531. doi:10.1038/sj.gene.6364010

    Article  PubMed  CAS  Google Scholar 

  27. Noguchi E, Nukaga-Nishio Y, Jian Z et al (2001) Haplotypes of the 5′ region of the IL-4 gene and SNPs in the intergene sequence between the IL-4 and IL-13 genes are associated with atopic asthma. Hum Immunol 62:1251–1257. doi:10.1016/S0198-8859(01)00338-X

    Article  PubMed  CAS  Google Scholar 

  28. Howard TD, Whittaker PA, Zaiman AL et al (2001) Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population. Am J Respir Cell Mol Biol 25:377–384

    PubMed  CAS  Google Scholar 

  29. van der Pouw Kraan TC, Küçükaycan M, Bakker AM et al (2002) Chronic obstructive pulmonary disease is associated with the −1055 IL-13 promoter polymorphism. Genes Immun 3:436–439. doi:10.1038/sj.gene.6363896

    Article  PubMed  CAS  Google Scholar 

  30. Excoffier L, Laval G, Schneider S (2005) Arlequin ver. 3.1: an integrated software package for population genetics data analysis. Evol Bioinform Online 1:47–50

    PubMed  CAS  Google Scholar 

  31. Wills-Karp M (2004) Interleukin-13 in asthma pathogenesis. Curr Allergy Asthma Rep 4:123–131. doi:10.1007/s11882-004-0057-6

    Article  PubMed  Google Scholar 

  32. Cameron L, Webster RB, Strempel JM et al (2006) Th2 cell-selective enhancement of human IL13 transcription by IL13–1112C>T, a polymorphism associated with allergic inflammation. J Immunol 177:8633–8642

    PubMed  CAS  Google Scholar 

  33. Heinzmann A, Jerkic SP, Ganter K et al (2003) Association study of the IL13 variant Arg110Gln in atopic diseases and juvenile idiopathic arthritis. J Allergy Clin Immunol 112:735–739. doi:10.1016/S0091-6749(03)01887-6

    Article  PubMed  CAS  Google Scholar 

  34. Arima K, Umeshita-Suyama R, Sakata Y et al (2002) Upregulation of IL-13 concentration in vivo by the IL13 variant associated with bronchial asthma. J Allergy Clin Immunol 109:980–987. doi:10.1067/mai.2002.124656

    Article  PubMed  CAS  Google Scholar 

  35. Graves PE, Kabesch M, Halonen M et al (2000) A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. J Allergy Clin Immunol 105:506–513. doi:10.1067/mai.2000.104940

    Article  PubMed  CAS  Google Scholar 

  36. Tazawa T, Sugiura H, Sugiura Y et al (2004) Relative importance of IL-4 and IL-13 in lesional skin of atopic dermatitis. Arch Dermatol Res 295:459–464. doi:10.1007/s00403-004-0455-6

    Article  PubMed  CAS  Google Scholar 

  37. Hamid Q, Naseer T, Minshall EM et al (1996) In vivo expression of IL-12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol 98:225–231. doi:10.1016/S0091-6749(96)70246-4

    Article  PubMed  CAS  Google Scholar 

  38. Schwartzbaum J, Ahlbom A, Malmer B et al (2005) Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res 65:6459–6465. doi:10.1158/0008-5472.CAN-04-3728

    Article  PubMed  CAS  Google Scholar 

  39. Sameni S, Ghayumi MA, Mortazavi G, et al (2008) Lack of association between interleukin-13 gene polymorphisms (−1055 C/T and +2044 G/A) in Iranian patients with lung cancer. Mol Biol Rep (May):28

Download references

Acknowledgments

This work was financially supported by a grant from Shiraz University of Medical Science (grant No. 83-2358) and also a grant from Shiraz Institute for Cancer Research (ICR) (grant No. ICR-8295), Shiraz, Iran. The authors would like to thank all patients and control individuals for their participation in this study. We are also grateful to our colleagues in Biobank section of ICR for DNA extracting.

Author information

Authors and Affiliations

  1. Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences, P.O. Box 71345-1798, Shiraz, Iran

    Zahra Faghih, Nasrollah Erfani, Mahboobeh Razmkhah, Safoura Sameni & Abbas Ghaderi

  2. Department of Immunology, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran

    Zahra Faghih & Abbas Ghaderi

  3. Department of Surgery, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran

    Abdolrasoul Talei

Authors
  1. Zahra Faghih
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nasrollah Erfani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mahboobeh Razmkhah
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Safoura Sameni
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Abdolrasoul Talei
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Abbas Ghaderi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Abbas Ghaderi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Faghih, Z., Erfani, N., Razmkhah, M. et al. Interleukin13 haplotypes and susceptibility of Iranian women to breast cancer. Mol Biol Rep 36, 1923–1928 (2009). https://doi.org/10.1007/s11033-008-9400-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-008-9400-7

Keywords

Search

Navigation